Science Explorer Back to mapMap
Discussion
Topic · Oncology

Global Cancer Incidence and Screening

Global Cancer Incidence and Screening is a research topic within Oncology. Science Explorer counts 43k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the global patterns of cancer incidence, mortality, and survival, with an emphasis on epidemiological research, health disparities, and the impact of various screening and preventive services. It covers a wide range of topics including breast cancer screening, risk factors for cancer, and the effectiveness of different healthcare interventions.

  • Cancer Incidence
  • Mortality Rates
  • Global Surveillance
  • Breast Cancer Screening
  • Epidemiological Research
  • Health Disparities
  • Cancer Survival
  • Risk Factors
  • Preventive Services
  • Population-Based Study
Research works
43k
fractional, since 1950
In the world top 10%
4.4k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+21%
the tick is no change
Largest producer
United States
54% of the 10 largest, 2022-now
Global Cancer Incidence and Screening

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Global Cancer Incidence and Screening research?

By volume, the United States and the United Kingdom publish the most (4k and 691 works in 2022-now).

By volume, 2022-now

  1. 1 United States 4k works
  2. 2 United Kingdom 691 works
  3. 3 China 643 works
  4. 4 India 437 works
  5. 5 Australia 364 works
  6. 6 Canada 333 works
  7. 7 Brazil 331 works
  8. 8 France 209 works
  9. 9 Iran 189 works
  10. 10 Italy 182 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 54.4%United Kingdom: 9.3%China: 8.7%India: 5.9%6 others listed: 21.7%54%largest
United States4,038 · 54.4%United Kingdom691 · 9.3%China643 · 8.7%India437 · 5.9%6 others listed1,608 · 21.7%

Shares of the rows listed above, not of the whole node.

Which institutions lead Global Cancer Incidence and Screening research?

By volume in 2022-now, Harvard University publishes the most Global Cancer Incidence and Screening research, followed by University of North Carolina at Chapel Hill and National Institutes of Health.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 146 works
  2. 2 University of North Carolina at Chapel HillUnited States 129 works
  3. 3 National Institutes of HealthUnited States 74 works
  4. 4 University of TorontoCanada 58 works
  5. 5 The University of Texas MD Anderson Cancer CenterUnited States 56 works
  6. 6 Johns Hopkins UniversityUnited States 54 works
  7. 7 Mayo ClinicUnited States 53 works
  8. 8 University of California, San FranciscoUnited States 51 works
  9. 9 University of PennsylvaniaUnited States 51 works
  10. 10 University of MichiganUnited States 51 works

Who are the leading researchers in Global Cancer Incidence and Screening?

The most-cited researchers publishing on Global Cancer Incidence and Screening include David Moher, Douglas G. Altman and Ahmedin Jemal.

  1. 1 David Moher Canada 898k citations
  2. 2 Douglas G. Altman United Kingdom 862k citations
  3. 3 Ahmedin Jemal United States 761k citations
  4. 4 Christopher J L Murray United States 583k citations
  5. 5 Rebecca L. Siegel United States 582k citations
  6. 6 Freddie Bray France 550k citations
  7. 7 Jacques Ferlay France 486k citations
  8. 8 Simon Iain Hay United States 452k citations
  9. 9 Theo Vos United States 439k citations
  10. 10 George Davey Smith United Kingdom 435k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Global Cancer Incidence and Screening?

The most cited paper in Global Cancer Incidence and Screening is "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries" (Hyuna Sung, Adalberto M. Filho, Mathieu Laversanne et al., 2021), with 114,522 citations. Next come "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" (88,280) and "Global cancer statistics" (55,108).

Most cited papers
#PaperReleasedCitations
1 Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries Hyuna Sung, Adalberto M. Filho, Mathieu Laversanne et al. · CA A Cancer Journal for Clinicians Open access 4 Feb 2021 114,522
2 Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians Open access 12 Sep 2018 88,280
3 Global cancer statistics Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians Open access 4 Feb 2011 55,108
4 Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 Jacques Ferlay, Isabelle Soerjomataram, Rajesh Prabhakar Dikshit et al. · International Journal of Cancer Open access 13 Sep 2014 29,250
5 Global cancer statistics, 2012 Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians Open access 4 Feb 2015 27,467
All 100 most cited papers, with filters and sorting

Where is Global Cancer Incidence and Screening research done?

The largest centres of Global Cancer Incidence and Screening research in 2022-now are London (United Kingdom), New York (United States), Boston (United States) and Philadelphia (United States).

Largest cities, 2022-now

  1. 1 LondonUnited Kingdom 223 works
  2. 2 New YorkUnited States 207 works
  3. 3 BostonUnited States 165 works
  4. 4 PhiladelphiaUnited States 128 works
  5. 5 Chapel HillUnited States 120 works
  6. 6 HoustonUnited States 113 works
  7. 7 AtlantaUnited States 112 works
  8. 8 BeijingChina 110 works
  9. 9 Los AngelesUnited States 104 works
  10. 10 SydneyAustralia 95 works
See Global Cancer Incidence and Screening on the map

Where is the best place to study Global Cancer Incidence and Screening?

Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Harvard University and Queen Mary University of London score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 17.11%fractional works in this field (log) →share of work in the world top 10% →Chinese Academy of M…Queen Mary Universit…Stanford UniversityHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 76.135.2%4.4×44 +84.4%
2Harvard UniversityUnited States 63.213.5%4.8×146 -6.7%
3Queen Mary University of LondonUnited Kingdom 61.722.4%5.5×23 +69.4%
4Stanford UniversityUnited States 55.616.0%2.9×41 +25.6%
5Yale UniversityUnited States 55.216.6%3.8×39 +19.5%
6University of GondarEthiopia 53.820.7%10.6×15 +64.3%
7University of California, San FranciscoUnited States 53.510.7%7.4×51 +5.6%
8University of Southern CaliforniaUnited States 53.113.5%4.7×38 +69.9%
9University of PennsylvaniaUnited States 52.810.7%5.0×51 +58.1%
10University of MiamiUnited States 52.111.8%7.8×46 +30.2%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Global Cancer Incidence and Screening, country by country

Is Global Cancer Incidence and Screening research growing?

Output in 2022-2025 was 21% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Global Cancer Incidence and Screening.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Global Cancer Incidence and Screening as a percentage of every work published that year, 0.043% in 2024.

still counting0.020%0.040%0.060%Global Cancer Incidence and Screening0.047% in 202519801990200020102020

Fractional works of Global Cancer Incidence and Screening over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Global Cancer Incidence and Screening9.9% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Global Cancer Incidence and Screening. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.